School of Medicine

WashU Medicine researchers led by Michael E. Belloy (left), an assistant professor of neurology and of psychiatry, identified key genetic targets for potential Alzheimer’s disease therapeutics development.

A movie trailer, local TV spot and documentaries produced by WashU Medicine Marketing & Communications recently won medals in the Telly awards, an international contest honoring excellence in TV and video production.

WashU Medicine researchers led a clinical trial testing three diets with different proportions of fat and carbohydrates and found all of them improved metabolic health, but a ketogenic plan had additional benefits for liver health and blood sugar control.

The biomarker test, called PrecivityAD2, was developed from technology invented at WashU Medicine by Randall J. Bateman, MD, and David M. Holtzman, MD.

Nathan Stitziel, MD, PhD, has received a $1.9 million grant from the Leducq Foundation to help lead an international collaboration aimed at identifying new therapeutic targets for cardiovascular disease and improving prevention.

Advances in medical imaging and artificial intelligence have revolutionized many aspects of medical practice, but it can be hard to know if a given measurement tool works as intended. A technique developed by WashU researchers can be used to assess the reliability of quantitative imaging tools.

WashU Medicine researchers discovered immune hubs in the skull bone marrow responsible for mounting a rapid immune response in the brain, which may point to new ways to fight brain cancer and neurodegenerative diseases.

Katherine Parker Ponder, MD, a highly accomplished physician-scientist whose career spanned decades at WashU Medicine, died July 18, 2026, of breast cancer. A memorial service will take place Sept. 19.

Thomas Kannampallil, a professor of anesthesiology at WashU Medicine, is recognized for his expertise in AI-based technology designed to improve healthcare.

The extent of tumor clearance and timing of treatment are important factors that help improve survival, according to a large analysis of patient outcomes by researchers at WashU Medicine.